Olfactory neuroblastoma: long-term clinical outcome at a single institute between 1979 and 2003

Acta Otolaryngol Suppl. 2007 Dec:(559):113-7. doi: 10.1080/03655230701599982.

Abstract

Conclusions: The progression of olfactory neuroblastoma showed a biphasic pattern. As well as Hyams' histopathological grading and neck metastasis at presentation, early phase recurrence should be regarded as an important prognosticator. A high local failure rate suggests that craniofacial resection followed by postoperative radiotherapy should still be the standard treatment for olfactory neuroblastoma.

Objective: The aim of this study was to evaluate factors associated with survival and local control of olfactory neuroblastoma in the long run and to estimate treatment strategies.

Patients and methods: Twelve patients (seven men and five women) who had undergone initial curative treatment for olfactory neuroblastoma were retrospectively analyzed.

Results: Cause-specific 10-year survival was 64.8%, while disease-free 10-year survival remained 28.6%. Local failure was found in half of the patients. All of the three patients who did not receive radiotherapy developed local failure. A biphasic pattern of recurrence was observed. The early phase recurrence group showed a significantly poorer survival than the late phase recurrence group. Hyams' histopathological grading and neck metastasis at presentation were also correlated with survival.

MeSH terms

  • Adult
  • Aged
  • Antineoplastic Agents / therapeutic use
  • Combined Modality Therapy
  • Esthesioneuroblastoma, Olfactory / epidemiology*
  • Esthesioneuroblastoma, Olfactory / pathology
  • Esthesioneuroblastoma, Olfactory / therapy*
  • Female
  • Follow-Up Studies
  • Humans
  • Incidence
  • Male
  • Middle Aged
  • Neoplasm Recurrence, Local
  • Neurosurgical Procedures
  • Peripheral Nervous System Neoplasms / epidemiology*
  • Peripheral Nervous System Neoplasms / pathology
  • Peripheral Nervous System Neoplasms / therapy*

Substances

  • Antineoplastic Agents